BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7533163)

  • 41. Characterization of functional domains of the tenascin-R (restrictin) polypeptide: cell attachment site, binding with F11, and enhancement of F11-mediated neurite outgrowth by tenascin-R.
    Nörenberg U; Hubert M; Brümmendorf T; Tárnok A; Rathjen FG
    J Cell Biol; 1995 Jul; 130(2):473-84. PubMed ID: 7615642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
    Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
    Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deleted in colorectal carcinoma (DCC) binds heparin via its fifth fibronectin type III domain.
    Bennett KL; Bradshaw J; Youngman T; Rodgers J; Greenfield B; Aruffo A; Linsley PS
    J Biol Chem; 1997 Oct; 272(43):26940-6. PubMed ID: 9341129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan.
    Hopf M; Göhring W; Mann K; Timpl R
    J Mol Biol; 2001 Aug; 311(3):529-41. PubMed ID: 11493006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
    Jalkanen S; Jalkanen M
    J Cell Biol; 1992 Feb; 116(3):817-25. PubMed ID: 1730778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular docking of heparin oligosaccharides with Hep-II heparin-binding domain of fibronectin reveals an interplay between the different positions of sulfate groups.
    Carpentier M; Denys A; Allain F; Vergoten G
    Glycoconj J; 2014 Feb; 31(2):161-9. PubMed ID: 24242364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin.
    Prieto AL; Andersson-Fisone C; Crossin KL
    J Cell Biol; 1992 Nov; 119(3):663-78. PubMed ID: 1383239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proliferation and transformation of cultured liver fat-storing cells (perisinusoidal lipocytes) under conditions of beta-D-xyloside-induced abrogation of proteoglycan synthesis.
    Gressner AM
    Exp Mol Pathol; 1991 Oct; 55(2):143-69. PubMed ID: 1718776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions between fibronectin and chondroitin sulfate are modulated by molecular context.
    Barkalow FJ; Schwarzbauer JE
    J Biol Chem; 1994 Feb; 269(6):3957-62. PubMed ID: 8307950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding.
    Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ
    Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation of chick tenascin variants and fragments. A C-terminal heparin-binding fragment produced by cleavage of the extra domain from the largest subunit splicing variant.
    Chiquet M; Vrucinić-Filipi N; Schenk S; Beck K; Chiquet-Ehrismann R
    Eur J Biochem; 1991 Jul; 199(2):379-88. PubMed ID: 1712728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.
    Hopf M; Göhring W; Kohfeldt E; Yamada Y; Timpl R
    Eur J Biochem; 1999 Feb; 259(3):917-25. PubMed ID: 10092882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of fibronectin interactions with glycosaminoglycans and identification of active proteolytic fragments.
    Yamada KM; Kennedy DW; Kimata K; Pratt RM
    J Biol Chem; 1980 Jul; 255(13):6055-63. PubMed ID: 6771264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins.
    Day JM; Olin AI; Murdoch AD; Canfield A; Sasaki T; Timpl R; Hardingham TE; Aspberg A
    J Biol Chem; 2004 Mar; 279(13):12511-8. PubMed ID: 14722076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The chicken neural extracellular matrix molecule restrictin: similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs.
    Nörenberg U; Wille H; Wolff JM; Frank R; Rathjen FG
    Neuron; 1992 May; 8(5):849-63. PubMed ID: 1375037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cooperative role for activated alpha4 beta1 integrin and chondroitin sulfate proteoglycans in cell adhesion to the heparin III domain of fibronectin. Identification of a novel heparin and cell binding sequence in repeat III5.
    Moyano JV; Carnemolla B; Albar JP; Leprini A; Gaggero B; Zardi L; Garcia-Pardo A
    J Biol Chem; 1999 Jan; 274(1):135-42. PubMed ID: 9867821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The NTR domain of procollagen C-proteinase enhancer-1 (PCPE-1) mediates PCPE-1 binding to syndecans-1, -2 and -4 as well as fibronectin.
    Weiss T; Brusel M; Rousselle P; Kessler E
    Int J Biochem Cell Biol; 2014 Dec; 57():45-53. PubMed ID: 25286301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping of a defined neurocan binding site to distinct domains of tenascin-C.
    Rauch U; Clement A; Retzler C; Fröhlich L; Fässler R; Göhring W; Faissner A
    J Biol Chem; 1997 Oct; 272(43):26905-12. PubMed ID: 9341124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and kinetics analysis of a novel heparin-binding site (KEDK) in human tenascin-C.
    Jang JH; Hwang JH; Chung CP; Choung PH
    J Biol Chem; 2004 Jun; 279(24):25562-6. PubMed ID: 15069070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple binding sites in fibronectin and the staphylococcal fibronectin receptor.
    Bozzini S; Visai L; Pignatti P; Petersen TE; Speziale P
    Eur J Biochem; 1992 Jul; 207(1):327-33. PubMed ID: 1385780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.